Listed

Inspire Medical Systems, Inc.

INSPNYSECIK 1609550HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$200.6m, Q2 FY2026
Operating income−$514.0k, Q2 FY2026
Net income$314.0k, Q2 FY2026
Inspire Medical Systems, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m153Revenue, Q3 FY2023, three months to 2023-09-30$153.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure193Revenue, Q4 FY2023, three months to 2023-12-31$192.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure164Revenue, Q1 FY2024, three months to 2024-03-31$164.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure196Revenue, Q2 FY2024, three months to 2024-06-30$195.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure203Revenue, Q3 FY2024, three months to 2024-09-30$203.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure240Revenue, Q4 FY2024, three months to 2024-12-31$239.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure201Revenue, Q1 FY2025, three months to 2025-03-31$201.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure217Revenue, Q2 FY2025, three months to 2025-06-30$217.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure225Revenue, Q3 FY2025, three months to 2025-09-30$224.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure269Revenue, Q4 FY2025, three months to 2025-12-31$269.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure205Revenue, Q1 FY2026, three months to 2026-03-31$204.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure201Revenue, Q2 FY2026, three months to 2026-06-30$200.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Cost of revenue$m24.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$24.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure28.1Cost of revenue, Q4 FY2023, three months to 2023-12-31$28.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure24.8Cost of revenue, Q1 FY2024, three months to 2024-03-31$24.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure29.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$29.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure32.4Cost of revenue, Q3 FY2024, three months to 2024-09-30$32.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure36.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$36.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure30.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$30.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure34.7Cost of revenue, Q2 FY2025, three months to 2025-06-30$34.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure31.8Cost of revenue, Q3 FY2025, three months to 2025-09-30$31.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure36.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$36.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure27.7Cost of revenue, Q1 FY2026, three months to 2026-03-31$27.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure29.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$29.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Gross profit$m129Gross profit, Q3 FY2023, three months to 2023-09-30$128.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure164Gross profit, Q4 FY2023, three months to 2023-12-31$164.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure139Gross profit, Q1 FY2024, three months to 2024-03-31$139.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure166Gross profit, Q2 FY2024, three months to 2024-06-30$166.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure171Gross profit, Q3 FY2024, three months to 2024-09-30$170.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure204Gross profit, Q4 FY2024, three months to 2024-12-31$203.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure171Gross profit, Q1 FY2025, three months to 2025-03-31$170.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure182Gross profit, Q2 FY2025, three months to 2025-06-30$182.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure193Gross profit, Q3 FY2025, three months to 2025-09-30$192.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure233Gross profit, Q4 FY2025, three months to 2025-12-31$233.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure177Gross profit, Q1 FY2026, three months to 2026-03-31$176.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure171Gross profit, Q2 FY2026, three months to 2026-06-30$171.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Research and development$m29.1Research and development, Q3 FY2023, three months to 2023-09-30$29.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure31.1Research and development, Q4 FY2023, three months to 2023-12-31$31.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure28.9Research and development, Q1 FY2024, three months to 2024-03-31$28.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure28.9Research and development, Q2 FY2024, three months to 2024-06-30$28.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure26.1Research and development, Q3 FY2024, three months to 2024-09-30$26.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure30.3Research and development, Q4 FY2024, three months to 2024-12-31$30.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure27.8Research and development, Q1 FY2025, three months to 2025-03-31$27.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure26.2Research and development, Q2 FY2025, three months to 2025-06-30$26.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure24.2Research and development, Q3 FY2025, three months to 2025-09-30$24.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure24.9Research and development, Q4 FY2025, three months to 2025-12-31$24.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure25.8Research and development, Q1 FY2026, three months to 2026-03-31$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure24.7Research and development, Q2 FY2026, three months to 2026-06-30$24.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Selling, general and administrative$mnot reportednot reported126Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$125.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure132Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$132.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure130Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$130.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure142Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$141.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure144Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$144.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure160Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$159.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure159Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$158.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure162Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$162.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure152Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$152.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure147Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$147.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Operating income$m(13.5)Operating income, Q3 FY2023, three months to 2023-09-30−$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure9.3Operating income, Q4 FY2023, three months to 2023-12-31$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Operating income, Q1 FY2024, three months to 2024-03-31−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure5.1Operating income, Q2 FY2024, three months to 2024-06-30$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure14.3Operating income, Q3 FY2024, three months to 2024-09-30$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure31.9Operating income, Q4 FY2024, three months to 2024-12-31$31.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Operating income, Q1 FY2025, three months to 2025-03-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure(3.3)Operating income, Q2 FY2025, three months to 2025-06-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure9.6Operating income, Q3 FY2025, three months to 2025-09-30$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure46.1Operating income, Q4 FY2025, three months to 2025-12-31$46.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(1.1)Operating income, Q1 FY2026, three months to 2026-03-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure(0.5)Operating income, Q2 FY2026, three months to 2026-06-30−$514.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-09, accession 0001609550-24-000016. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$22.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Interest expense, Q2 FY2025, three months to 2025-06-30$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$11.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure0.1Interest expense, Q4 FY2025, three months to 2025-12-31$122.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$m0.3Income tax, Q3 FY2023, three months to 2023-09-30$340.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure0.5Income tax, Q4 FY2023, three months to 2023-12-31$477.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.7Income tax, Q1 FY2024, three months to 2024-03-31$650.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure1.1Income tax, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure1.8Income tax, Q3 FY2024, three months to 2024-09-30$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure1.4Income tax, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure1.2Income tax, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure1.3Income tax, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure3.6Income tax, Q3 FY2025, three months to 2025-09-30$3.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure(85.8)Income tax, Q4 FY2025, three months to 2025-12-31−$85.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure13.7Income tax, Q1 FY2026, three months to 2026-03-31$13.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure2.8Income tax, Q2 FY2026, three months to 2026-06-30$2.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Net income$m(8.5)Net income, Q3 FY2023, three months to 2023-09-30−$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure14.8Net income, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(10.0)Net income, Q1 FY2024, three months to 2024-03-31−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure9.8Net income, Q2 FY2024, three months to 2024-06-30$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure18.5Net income, Q3 FY2024, three months to 2024-09-30$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure35.2Net income, Q4 FY2024, three months to 2024-12-31$35.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure3.0Net income, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure(3.6)Net income, Q2 FY2025, three months to 2025-06-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure9.9Net income, Q3 FY2025, three months to 2025-09-30$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure136Net income, Q4 FY2025, three months to 2025-12-31$136.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Net income, Q1 FY2026, three months to 2026-03-31−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure0.3Net income, Q2 FY2026, three months to 2026-06-30$314.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Diluted EPS$ per share(0.29)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figurenot reported(0.34)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure0.32Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure0.60Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figurenot reported0.10Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure0.34Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figurenot reported(0.39)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure0.01Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Basic EPS$ per share(0.29)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figurenot reported(0.34)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure0.33Basic EPS, Q2 FY2024, three months to 2024-06-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure0.62Basic EPS, Q3 FY2024, three months to 2024-09-30$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figurenot reported0.10Basic EPS, Q1 FY2025, three months to 2025-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure0.34Basic EPS, Q3 FY2025, three months to 2025-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figurenot reported(0.39)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure0.01Basic EPS, Q2 FY2026, three months to 2026-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure

Balance sheet

Cash and equivalents$127.8m, Q2 FY2026
Shareholders' equity$825.6m, Q2 FY2026
Inspire Medical Systems, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m330Cash and equivalents, Q3 FY2023, at 2023-09-30$329.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure186Cash and equivalents, FY2023, at 2023-12-31$185.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-10, accession 0001609550-25-000011.Report this figure175Cash and equivalents, Q1 FY2024, at 2024-03-31$175.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001609550-24-000026.Report this figure188Cash and equivalents, Q2 FY2024, at 2024-06-30$188.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001609550-24-000044.Report this figure148Cash and equivalents, Q3 FY2024, at 2024-09-30$147.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure150Cash and equivalents, FY2024, at 2024-12-31$150.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-13, accession 0001609550-26-000016.Report this figure53.9Cash and equivalents, Q1 FY2025, at 2025-03-31$53.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure107Cash and equivalents, Q2 FY2025, at 2025-06-30$106.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure113Cash and equivalents, Q3 FY2025, at 2025-09-30$112.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure105Cash and equivalents, FY2025, at 2025-12-31$104.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure98.9Cash and equivalents, Q1 FY2026, at 2026-03-31$98.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure128Cash and equivalents, Q2 FY2026, at 2026-06-30$127.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Current assets$m570Current assets, Q3 FY2023, at 2023-09-30$569.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure594Current assets, FY2023, at 2023-12-31$593.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-10, accession 0001609550-25-000011.Report this figure572Current assets, Q1 FY2024, at 2024-03-31$572.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001609550-24-000026.Report this figure607Current assets, Q2 FY2024, at 2024-06-30$607.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001609550-24-000044.Report this figure583Current assets, Q3 FY2024, at 2024-09-30$582.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure631Current assets, FY2024, at 2024-12-31$630.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-13, accession 0001609550-26-000016.Report this figure572Current assets, Q1 FY2025, at 2025-03-31$571.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure573Current assets, Q2 FY2025, at 2025-06-30$573.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure586Current assets, Q3 FY2025, at 2025-09-30$586.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure584Current assets, FY2025, at 2025-12-31$583.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure567Current assets, Q1 FY2026, at 2026-03-31$566.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure609Current assets, Q2 FY2026, at 2026-06-30$608.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Total assets$m639Total assets, Q3 FY2023, at 2023-09-30$639.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure677Total assets, FY2023, at 2023-12-31$676.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-10, accession 0001609550-25-000011.Report this figure686Total assets, Q1 FY2024, at 2024-03-31$685.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001609550-24-000026.Report this figure728Total assets, Q2 FY2024, at 2024-06-30$728.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001609550-24-000044.Report this figure796Total assets, Q3 FY2024, at 2024-09-30$796.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure808Total assets, FY2024, at 2024-12-31$808.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-13, accession 0001609550-26-000016.Report this figure731Total assets, Q1 FY2025, at 2025-03-31$730.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure802Total assets, Q2 FY2025, at 2025-06-30$802.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure808Total assets, Q3 FY2025, at 2025-09-30$807.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure907Total assets, FY2025, at 2025-12-31$907.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure911Total assets, Q1 FY2026, at 2026-03-31$911.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure926Total assets, Q2 FY2026, at 2026-06-30$926.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Current liabilities$m70.0Current liabilities, Q3 FY2023, at 2023-09-30$70.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure78.1Current liabilities, FY2023, at 2023-12-31$78.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-10, accession 0001609550-25-000011.Report this figure72.2Current liabilities, Q1 FY2024, at 2024-03-31$72.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001609550-24-000026.Report this figure65.7Current liabilities, Q2 FY2024, at 2024-06-30$65.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001609550-24-000044.Report this figure74.3Current liabilities, Q3 FY2024, at 2024-09-30$74.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure88.5Current liabilities, FY2024, at 2024-12-31$88.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-13, accession 0001609550-26-000016.Report this figure63.5Current liabilities, Q1 FY2025, at 2025-03-31$63.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure93.4Current liabilities, Q2 FY2025, at 2025-06-30$93.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure111Current liabilities, Q3 FY2025, at 2025-09-30$110.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure96.1Current liabilities, FY2025, at 2025-12-31$96.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure89.4Current liabilities, Q1 FY2026, at 2026-03-31$89.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure71.2Current liabilities, Q2 FY2026, at 2026-06-30$71.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Total liabilities$m95.3Total liabilities, Q3 FY2023, at 2023-09-30$95.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure104Total liabilities, FY2023, at 2023-12-31$104.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-10, accession 0001609550-25-000011.Report this figure96.8Total liabilities, Q1 FY2024, at 2024-03-31$96.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001609550-24-000026.Report this figure90.3Total liabilities, Q2 FY2024, at 2024-06-30$90.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001609550-24-000044.Report this figure99.6Total liabilities, Q3 FY2024, at 2024-09-30$99.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure119Total liabilities, FY2024, at 2024-12-31$118.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-13, accession 0001609550-26-000016.Report this figure95.1Total liabilities, Q1 FY2025, at 2025-03-31$95.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure124Total liabilities, Q2 FY2025, at 2025-06-30$124.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure141Total liabilities, Q3 FY2025, at 2025-09-30$141.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure126Total liabilities, FY2025, at 2025-12-31$126.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure119Total liabilities, Q1 FY2026, at 2026-03-31$119.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure100Total liabilities, Q2 FY2026, at 2026-06-30$100.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m544Shareholders' equity, Q3 FY2023, at 2023-09-30$544.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure573Shareholders' equity, FY2023, at 2023-12-31$572.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-13, accession 0001609550-26-000016.Report this figure589Shareholders' equity, Q1 FY2024, at 2024-03-31$589.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure638Shareholders' equity, Q2 FY2024, at 2024-06-30$638.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure697Shareholders' equity, Q3 FY2024, at 2024-09-30$696.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure690Shareholders' equity, FY2024, at 2024-12-31$689.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure636Shareholders' equity, Q1 FY2025, at 2025-03-31$635.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure678Shareholders' equity, Q2 FY2025, at 2025-06-30$677.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure666Shareholders' equity, Q3 FY2025, at 2025-09-30$666.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure781Shareholders' equity, FY2025, at 2025-12-31$781.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure792Shareholders' equity, Q1 FY2026, at 2026-03-31$792.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure826Shareholders' equity, Q2 FY2026, at 2026-06-30$825.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure

Cash flow

Operating cash flow$23.2m, Q2 FY2026
Capital expenditure$9.2m, Q2 FY2026
Share repurchases$0, Q2 FY2026
Inspire Medical Systems, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m3.6Operating cash flow, Q3 FY2023, three months to 2023-09-30$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0001609550-24-000053. Derived: 9-month figure less the 6-month figure.Report this figure17.3Operating cash flow, Q4 FY2023, three months to 2023-12-31$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure8.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure(0.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$78.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-04, accession 0001609550-25-000032. Derived: 6-month figure less the 3-month figure.Report this figure52.3Operating cash flow, Q3 FY2024, three months to 2024-09-30$52.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001609550-25-000053. Derived: 9-month figure less the 6-month figure.Report this figure69.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$69.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure2.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001609550-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure68.5Operating cash flow, Q3 FY2025, three months to 2025-09-30$68.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001609550-25-000053. Derived: 9-month figure less the 6-month figure.Report this figure52.5Operating cash flow, Q4 FY2025, three months to 2025-12-31$52.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure12.8Operating cash flow, Q1 FY2026, three months to 2026-03-31$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure23.2Operating cash flow, Q2 FY2026, three months to 2026-06-30$23.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001609550-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m7.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$7.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-04, accession 0001609550-24-000053. Derived: 9-month figure less the 6-month figure.Report this figure8.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$8.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure11.7Capital expenditure, Q1 FY2024, three months to 2024-03-31$11.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure12.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$12.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-04, accession 0001609550-25-000032. Derived: 6-month figure less the 3-month figure.Report this figure8.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$8.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001609550-25-000053. Derived: 9-month figure less the 6-month figure.Report this figure7.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$7.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure8.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$8.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure9.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$9.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001609550-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure10.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$10.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001609550-25-000053. Derived: 9-month figure less the 6-month figure.Report this figure10.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$10.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure9.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$9.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure9.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$9.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001609550-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reported0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-04, accession 0001609550-25-000032. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-03, accession 0001609550-25-000053. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure75.0Share repurchases, Q1 FY2025, three months to 2025-03-31$75.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-03, accession 0001609550-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure50.0Share repurchases, Q3 FY2025, three months to 2025-09-30$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-03, accession 0001609550-25-000053. Derived: 9-month figure less the 6-month figure.Report this figure50.0Share repurchases, Q4 FY2025, three months to 2025-12-31$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-13, accession 0001609550-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-03, accession 0001609550-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)28.94m, Q2 FY2026
Inspire Medical Systems, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares28.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3028,226,345 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001609550-23-000063.Report this figure29.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3129,089,950 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001609550-24-000026.Report this figure29.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3029,229,922 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001609550-24-000044.Report this figure29.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3029,365,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001609550-24-000053.Report this figure29.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,615,166 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001609550-25-000020.Report this figure30.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3030,408,439 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-04, accession 0001609550-25-000032.Report this figure30.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3030,633,789 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure30.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3130,311,476 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure29.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3029,506,807 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure29.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3029,600,223 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001609550-25-000053.Report this figure28.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3128,700,525 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001609550-26-000023.Report this figure28.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3028,940,846 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure

Shares outstanding: 28.91mShares outstanding, period not labelled, at 2026-07-3028,910,375 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001609550-26-000047.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.